Optimal dosing of atypical antipsychotics in adults: a review of the current evidence.
about
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.A systematic review of meta-analyses of the efficacy of oral atypical antipsychotics for the treatment of adult patients with schizophrenia.Optimizing dosing in atypical neuroleptic monotherapyRelationship of atypical antipsychotics with development of diabetes mellitus.The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning.Trends in the use of antipsychotics in the Israeli inpatient population, 2004-2013.Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophreniaAn alternative approach to measuring treatment persistence with antipsychotic agents among patients with schizophrenia in the Veterans Health Administration.A review of aripiprazole in the treatment of patients with schizophrenia or bipolar I disorder.Measurement of treatment adherence with antipsychotic agents in patients with schizophreniaAre we using excessive neuroleptics? An argument for systematic neuroleptic dose reduction in stable patients with schizophrenia with specific reference to clozapine.Treatment strategies for dosing the second generation antipsychotics.Adjunctive use of atypical antipsychotics and anticholinergic drugs among patients with schizophrenia.Effectiveness of antipsychotics: is the CATIE trial a tsunami?ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients.Antipsychotic drugs and risk of pulmonary embolism.A comparison of ziprasidone and risperidone in the long-term treatment of schizophrenia: a 44-week, double-blind, continuation study.Clinical experience with atypical antipsychotics in an acute inpatient unit: focus on quetiapine.
P2860
Q33223628-4548BD8E-8241-41DB-A72B-9B456A0B0DBFQ34097289-3AB976B1-618D-436A-9424-C71E882B342AQ34183522-BC790700-3077-4139-8A82-4AA751CCBAF1Q34224372-642C7E62-B213-4C7E-892D-6C9A776D63A1Q35236514-BFD335BB-AF2D-4C9B-BADC-BB7EEA30A80CQ35591014-C7D7D57D-0147-4A08-AA4A-05B02D5A3F6DQ35930948-EED40999-F2C4-49DA-9405-F688F3265ED3Q37006387-D976FA0C-6DBF-455B-B79D-4874A3C13573Q37075939-F9684BF0-62F8-4EE5-976B-BD68DF4540A7Q37125756-AD84DA33-8673-4C2D-87FA-8D4F3F89A9C2Q37166131-3B9A4379-DB8C-4296-9324-21BF55A6B04DQ37388468-08A33B6B-E3A6-4401-A22B-EEBB672DD456Q37760926-ED98EDA7-B40A-4E3E-B06A-96AB95E4755FQ37852818-21BAD901-CA46-4473-97AE-6647B344ECC5Q40453295-AFDF179A-D14E-4AF0-A5D2-BC73BF10617FQ42133970-0B697CA5-3D56-40CD-9C18-702AAA298DB8Q43296441-4481E878-E6D9-4765-AB06-36A434550A7CQ44455246-BA55E749-1EAE-4683-9B5A-75DF8DC97BC7Q46142676-1E484566-74DB-4D9C-B146-55CD45B7B107Q51922801-C1B9DB73-0D7A-41B9-898C-506DC2578517
P2860
Optimal dosing of atypical antipsychotics in adults: a review of the current evidence.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Optimal dosing of atypical antipsychotics in adults: a review of the current evidence.
@ast
Optimal dosing of atypical antipsychotics in adults: a review of the current evidence.
@en
Optimal dosing of atypical antipsychotics in adults: a review of the current evidence.
@nl
type
label
Optimal dosing of atypical antipsychotics in adults: a review of the current evidence.
@ast
Optimal dosing of atypical antipsychotics in adults: a review of the current evidence.
@en
Optimal dosing of atypical antipsychotics in adults: a review of the current evidence.
@nl
prefLabel
Optimal dosing of atypical antipsychotics in adults: a review of the current evidence.
@ast
Optimal dosing of atypical antipsychotics in adults: a review of the current evidence.
@en
Optimal dosing of atypical antipsychotics in adults: a review of the current evidence.
@nl
P356
P1476
Optimal dosing of atypical antipsychotics in adults: a review of the current evidence.
@en
P2093
Jan Volavka
P304
P356
10.1080/10673220216279
P577
2002-09-01T00:00:00Z